Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
12/2003
12/11/2003US20030229093 Lipid diseases; metabolism diosrders; antiproliferative agents
12/11/2003US20030229054 Novel amines as pharmaceutical agents
12/11/2003US20030229053 Compounds and methods for the treatment or prevention of flavivirus infections
12/10/2003EP1369134A1 New agents for magnetic imaging method
12/10/2003EP1367888A2 Selective substituted aryl ketone and safener based herbicides
12/10/2003EP0970046B1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors
12/10/2003CN1130126C Tetrazolinones as herbicides for use in rice field
12/09/2003US6660832 Macrocyclic compounds and preparation methods thereof
12/09/2003US6660760 Heterocyclic aromatic compounds useful as growth hormone secretagogues
12/04/2003WO2003066673A8 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof
12/04/2003US20030225087 N-alkyl-N-phenylhydroxylamine compounds containing metal chelating groups, their preparation and their therapeutic uses
12/04/2003US20030225074 E.g., 2-((4'-Methoxy(1,1'-biphenyl)-4-yl)sulfonyl)amino-4-hydroxy-5-((2 -thiazolyl)thio)-pentanoic Acid
12/04/2003US20030225059 Cyclohexyl derivatives and their use as therapeutic agents
12/04/2003US20030225043 Especially for inhibiting type IV collagenase
12/04/2003US20030224943 Novel tetrazole derivatives
12/03/2003EP1366024A2 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
12/03/2003EP1366012A2 2-aryloxy-2-arylalkanoic acids for diabetes and lipid disorders
12/03/2003EP0973395B1 Diaryl ethers and processes for their preparation and herbicidal and desiccant compositions containing them
11/2003
11/27/2003WO2003097619A1 Glucagon antagonists/inverse agonists
11/27/2003WO2003097163A2 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003WO2003097050A2 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/27/2003WO2003097045A1 Combination of organic compounds
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220402 Secondary carbocyclic amides such as 2-(4-(2-naphthyloxy)-benzamido)benzoic acid methyl ester, used as anticarcinogenic agents
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220323 Such as (2-(4-(2-(1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy)-1-phenyl-ethyl) -piperazin-1-yl)-ethoxy)-acetic acid; for prevention and/or treatment of conditions associated with pathogical levels of substance P
11/27/2003US20030220315 Such as 3',3"-dibromo-4',4"-dimethoxy-5',5"-bis-(methoxycarbonyl)-1,1 -diphenylethene; for treating viral diseases/retroviruses
11/27/2003CA2486061A1 Using a selective inos inhibitor for the treatment of respiratory diseases and conditions
11/27/2003CA2484654A1 A selective inos inhibitor and a pde inhibitor in combination for the treatment of respiratory diseases
11/26/2003EP1363915A1 Substituted calix (4) pyrroles and process for the synthesis of calix (4) pyrroles over molecular sieve catalysts
11/26/2003EP1363908A1 ANTI-CANCER 2,3-DIHYDRO-1H-PYRROLO 3,2-f]QUINOLINE COMPLEXES OF COBALT AND CHROMIUM
11/26/2003EP1363879A2 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
11/26/2003EP1144380A4 A meta-nitro phenol derivative and a process for producing it
11/25/2003USRE38329 Contrast agents for magnetic resonance imaging
11/25/2003US6653470 Process for the preparation of 1,4,7,10-tetraazacyclododecane
11/25/2003US6653304 Antiarthritic agents; skin disorders; anticarcinogenic agents
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652834 Tensioactive properties, long lasting activity in the blood pool
11/20/2003WO2003095398A2 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/20/2003CA2485167A1 Polydiazeniumdiolated cyclic polyamines with polyphasic nitric oxide release and related compounds, compositions comprising same and methods of using same
11/19/2003EP1361876A2 Novel cannabimimetic ligands
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649641 Glucagon antagonists/inverse agonists
11/13/2003WO2003093248A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors
11/13/2003WO2003092670A1 Bombesin antagonists
11/13/2003WO2003076417A3 Oxo-azabicyclic compounds
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003US20030212093 Imidazonaphthyridines
11/13/2003CA2484582A1 Bombesin antagonists
11/11/2003US6645965 Nitrate salts of antihypertensive medicines
11/11/2003CA2055637C Method for the treatment of cardiac and of vascular hypertrophy and hyperplasia
11/06/2003WO2003035626A3 Azole derivatives and pharmaceutical compositions containing them
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003US20030207930 Valsartan salts
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207823 Novel diabetes imaging probes
11/05/2003EP0902007B1 Chalcone derivatives and drugs containing the same
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003089417A1 Novel crystalline forms of (s)-n-(1-carboxy-2-methyl-prop-1-yl) -n-pentanoyl-n- [2’-(1h-tetrazol-5-yl-)- biphenyl-4-yl methyl] amine (valsartan)
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030203946 Glucagon antagonists/inverse agonists
10/30/2003US20030203945 Coupling a heterocyclic compound containing amine group with a 4-nitrophenyl-1-oxycarbonyl or derivative useful for the treatment of neurological conditions
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0946526B1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086563A2 Diabetes imaging probes
10/23/2003US20030199698 Anticoagulants such as 2'-tert-butylaminosulfonylbiphenyl-4-yl-(3-(5-methyl-1,2,4-oxadiazol-3 -yl)benzyl)(2-cyanoethyl) carbamate, used for prophylaxis of cardiovascular disorders
10/23/2003US20030199510 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity
10/23/2003US20030198880 Charge transport material comprising a fluorenone hydrazone having a) least two fluorenone alkylsulfonylphenylhydrazone groups, b) at least two fluorenone pyrrolylhydrazone groups, c) at least two fluorenone benzotriazolylhydrazone groups, d)
10/23/2003CA2480856A1 Substituted aryl amides
10/22/2003EP1354871A1 Biphenyl derivatives
10/22/2003EP1353662A2 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
10/21/2003US6635655 Agonists or antagonists of peroxisome proliferator-activated receptors
10/16/2003WO2002036118A3 Heterocyclic derivatives useful as pharmaceutical agents
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/14/2003CA2291994C Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082861A2 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003CA2480106A1 Morpholinyl-urea derivatives for use of the treatment of inflammatory diseases
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003US20030187043 Substituted n-benzoyl-n'(tetrazolylphenyl)-ureas and their use as pest control agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030186944 Novel aromatic compounds
10/01/2003EP1348443A1 Combination drugs
10/01/2003CN1445615A Electric photographic organic photoreceptor with new charge transfer matter
10/01/2003CN1122665C Herbicidal N-alkenyl heteroaryloxyacetamides
10/01/2003CN1122664C Process for preparation of 1,4,7,10-tetraazacyclododecane
09/2003
09/25/2003WO2002030884A3 Sulfide and disulfide compounds and compositions for cholesterol management and related uses
09/25/2003WO2002030882A3 Sulfoxide and bis-sulfoxide compounds and compositions for cholesterol management and related uses
09/25/2003US20030180236 Resorcinol derivatives
1 ... 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 ... 97